This inventor holds 1 USPTO granted patent. Top assignee: Lg Chemical Ltd.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Mi-Kyeong Seo: Innovator in Ophthalmic Formulations
Introduction
Mi-Kyeong Seo is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of myopia. His innovative approach combines pharmacological agents with advanced formulation techniques.
Latest Patents
Mi-Kyeong Seo holds a patent for an ophthalmic formulation designed to treat myopia. This formulation comprises a dopamine agonist and cyclodextrin or its derivative, combined with a pharmaceutically acceptable carrier. This innovative solution aims to provide effective treatment options for individuals suffering from myopia.
Career Highlights
Mi-Kyeong Seo is associated with LG Chemical Ltd., a leading company in the chemical industry. His work at LG Chemical Ltd. has allowed him to focus on developing cutting-edge solutions in ophthalmic care. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Mi-Kyeong Seo has collaborated with notable colleagues, including Yong-Hee Lee and Yun-Jeong Choi. These partnerships have fostered a collaborative environment that enhances innovation and drives advancements in ophthalmic formulations.
Conclusion
Mi-Kyeong Seo's contributions to ophthalmic formulations highlight his commitment to improving treatment options for myopia. His innovative work continues to influence the field and offers hope for better vision care solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile